Quote Obinutuzumab
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
Read more
€0.00
(tax incl.)
Reference:
HY-P9910
Brand: